Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Julphar
UBS
Chubb
Daiichi Sankyo
Express Scripts
Colorcon
Healthtrust

Generated: May 21, 2018

DrugPatentWatch Database Preview

CYCLAPEN-W Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Cyclapen-w patents expire, and what generic alternatives are available?

Cyclapen-w is a drug marketed by Wyeth Ayerst and is included in two NDAs.

The generic ingredient in CYCLAPEN-W is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
Summary for CYCLAPEN-W
Drug patent expirations by year for CYCLAPEN-W
Medical Subject Heading (MeSH) Categories for CYCLAPEN-W
Synonyms for CYCLAPEN-W
(1-Aminocyclohexyl)penicillin
(2S,5R,6R)-6-(1-aminocyclohexaneamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(1-aminocyclohexane)amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(Aminocyclohexyl)penicillin
3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3485-14-1
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((1-aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo- (8CI)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI)
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-
6-(1-Aminocyclohexanecarboxamido)-3
6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(1-Aminocyclohexanecarboxamido)penicillanic acid
6-(1-Aminocyclohexylcarboxamido)penicillanic acid
6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid
72ZJ154X86
AB00514059
AC 98
AC-PC
AC1L2D99
AKOS030530775
Aminocyclohexyl penicillin
Aminocyclohexylpenicillin
Bastcillin
BDBM50350474
BPBio1_001385
BRD-K89046952-001-03-4
BRN 0938663
BSPBio_001260
C-12104
C12766
Calthor
CAS-3485-14-1
CHEBI:31444
CHEMBL1200356
Ciclacilina
Ciclacilina [INN-Spanish]
ciclacillin
Ciclacillin (JP15/INN)
Ciclacillin (JP17/INN)
Ciclacilline
Ciclacilline [INN-French]
Ciclacillinum
Ciclacillinum [INN-Latin]
Ciclacillum
Citosarin
CTK1C2902
CYCLACILLIN
CYCLACILLIN (200 MG)
Cyclacillin (USAN)
Cyclacillin [USAN:USP]
Cyclacillin [USAN]
Cyclapen
Cyclapen (TN)
Cyclapen-W (TN)
D00HWO
D01334
DB01000
DSSTox_CID_2861
DSSTox_GSID_22861
DSSTox_RID_76762
DTXSID9022861
EINECS 222-470-8
GTPL4817
HE063275
HE337242
HGBLNBBNRORJKI-WCABBAIRSA-N
HMS1571O22
LS-55797
MLS002694856
NCGC00016629-01
NCGC00179238-01
NCI60_041965
Noblicil
NSC 88789
NSC-88789
NSC88789
Orfilina
Peamezin
Penicillin, (aminocyclohexyl)-
Prestwick0_001120
Prestwick1_001120
Prestwick2_001120
Prestwick3_001120
SCHEMBL33900
SPBio_003120
Syngacillin
Tox21_110534
Ultracillin
UNII-72ZJ154X86
Vastcillin
Vastcillin (TN)
Vipicil
WLN: T45 ANV ESTJ F1 F1 GVQ CMV- AL6TJ AZ
WY 4508
Wy-4508
WY4508
Wyvital
ZINC3830609

US Patents and Regulatory Information for CYCLAPEN-W

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst CYCLAPEN-W cyclacillin FOR SUSPENSION;ORAL 050508-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst CYCLAPEN-W cyclacillin TABLET;ORAL 050509-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst CYCLAPEN-W cyclacillin FOR SUSPENSION;ORAL 050508-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst CYCLAPEN-W cyclacillin FOR SUSPENSION;ORAL 050508-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Teva
Accenture
McKesson
Citi
US Department of Justice
AstraZeneca
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.